v3.26.1
Psyence Labs Ltd. Investment and Investment in Associate (Details) - USD ($)
 1 Months Ended 12 Months Ended
Feb. 25, 2026
Mar. 31, 2025
Mar. 31, 2026
Mar. 31, 2026
Mar. 31, 2025
Mar. 31, 2024
Feb. 11, 2026
Aug. 15, 2025
Jul. 03, 2025
Apr. 15, 2025
Psyence Labs Ltd. Investment and Investment in Associate [Line Items]                    
Number of shares issued (in Shares)   94 2,439 2,439 94          
Consideration of shares (in Shares)   5,695                
Fair value of shares issued   $ 722,033     $ 722,033          
Fair value of investment     $ 5,172,000 $ 5,172,000            
Third-party investor       1,724 745          
Additional shares (in Shares)               1,750   250
Total consideration     $ 2,934,167 2,934,167       $ 3,500,000   $ 500,000
Acquisitions shares held (in Shares)               3,000    
Percentage of outstanding shares               16.46%    
Unrealized fair value gain       $ 427,000 22,967          
Price per share (in Dollars per share) $ 2.56   $ 24.61 $ 24.61     $ 4.3624      
Fixed consideration amount             $ 5,000,000      
Remeasured carrying amount       $ 5,172,000            
Percentage of equity method post acquisition 27.93%                  
Net loss     $ (45,239) $ (45,239)        
Bottom of range [Member]                    
Psyence Labs Ltd. Investment and Investment in Associate [Line Items]                    
Percentage of ownership interest 16.46%                  
Top of range [Member]                    
Psyence Labs Ltd. Investment and Investment in Associate [Line Items]                    
Percentage of ownership interest 27.93%                  
Psyence Labs Ltd. [Member]                    
Psyence Labs Ltd. Investment and Investment in Associate [Line Items]                    
Number of shares issued (in Shares)   1,000     1,000       2,900  
Fair value of investment   $ 745,000     $ 745,000          
Third-party investor         $ 745          
PBM [Member]                    
Psyence Labs Ltd. Investment and Investment in Associate [Line Items]                    
Number of shares issued (in Shares)             1,146,159      
Common Shares [Member]                    
Psyence Labs Ltd. Investment and Investment in Associate [Line Items]                    
Number of shares issued (in Shares)   90,883 2,293,277 2,293,277 90,883          
Price per share (in Dollars per share)     $ 17,895.14 $ 17,895.14            
Common Shares [Member] | Psyence Labs Ltd. [Member]                    
Psyence Labs Ltd. Investment and Investment in Associate [Line Items]                    
Number of shares issued (in Shares) 1,146,159                  
Remeasurement of Previously Held Interest [Member]                    
Psyence Labs Ltd. Investment and Investment in Associate [Line Items]                    
Number of shares issued (in Shares)     3,000 3,000            
Price per share (in Dollars per share)     $ 1,724 $ 1,724            
Consideration Transferred for Additional Shares [Member]                    
Psyence Labs Ltd. Investment and Investment in Associate [Line Items]                    
Number of shares issued (in Shares)     2,900 2,900            
Total consideration     $ 1,146,159 $ 1,146,159